Home Institutions Northwestern Medicine clinical trials Institution Directory
Clinical trials at Northwestern Medicine Sites in Chicago, IL
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 23, 2026, 2:01 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1131
Current sort
Recently updated
Campus scope
Northwestern Medicine, Chicago, IL
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 445–456 of 1,131 matching trials with a site at Northwestern Medicine, Chicago, IL.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma, Recurrent WHO Grade 4 Glioma
Interventions Biospecimen Collection, Magnetic Resonance Imaging, Questionnaire Administration, Resection, Temozolomide, Triapine Procedure · Other · Drug
Lead sponsor Northwestern University Other
Eligibility 18 Years and older
Enrollment 22 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2030
U.S. locations 1
States / cities Chicago, Illinois
Conditions Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Interventions Not listed
Lead sponsor The European Forum for Research and Education in Allergy and Airway Diseases Other
Eligibility 18 Years and older
Enrollment 1,000 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2027
U.S. locations 5
States / cities Santa Monica, California • Chicago, Illinois • Boston, Massachusetts + 2 more
Conditions Areata Alopecia, Alopecia, Hypotrichosis, Hair Diseases, Skin Diseases, Pathological Conditions, Anatomical
Interventions Baricitinib, Placebo Drug
Lead sponsor Eli Lilly and Company Industry
Eligibility 6 Years to 17 Years
Enrollment 595 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2033
U.S. locations 44
States / cities Birmingham, Alabama • Scottsdale, Arizona • Encinitas, California + 38 more
Conditions Locally Advanced Unresectable Primary Central Chondrosarcoma, Metastatic Primary Central Chondrosarcoma, Unresectable Primary Central Chondrosarcoma
Interventions Belinostat, Biopsy Procedure, Biospecimen Collection, Computed Tomography, Decitabine and Cedazuridine, Guadecitabine, Magnetic Resonance Imaging Drug · Procedure
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 19 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 39
States / cities Phoenix, Arizona • Duarte, California • Los Angeles, California + 32 more
Conditions Idiopathic Pulmonary Fibrosis
Interventions Metformin, Matching Placebo Drug
Lead sponsor University of Massachusetts, Worcester Other
Eligibility 40 Years and older
Enrollment 800 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2029
U.S. locations 15
States / cities Tucson, Arizona • Aurora, Colorado • Washington D.C., District of Columbia + 11 more
Conditions Deep Vein Thrombosis, DVT
Interventions Indigo Aspiration System Device
Lead sponsor Penumbra Inc. Industry
Eligibility 18 Years and older
Enrollment 229 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2028
U.S. locations 42
States / cities La Mesa, California • Long Beach, California • Los Angeles, California + 32 more
Conditions Skin Angiosarcoma, Skin Radiation-Related Angiosarcoma, Visceral Angiosarcoma
Interventions Biospecimen Collection, Cabozantinib S-malate, Computed Tomography, FDG-Positron Emission Tomography, Magnetic Resonance Imaging, Nivolumab, Paclitaxel, Quality-of-Life Assessment, Questionnaire Administration Procedure · Drug · Biological + 1 more
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 90 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 170
States / cities Phoenix, Arizona • Scottsdale, Arizona • Tucson, Arizona + 120 more
Conditions Coronary Artery Calcification, Coronary Artery Disease, Stenotic Coronary Lesion
Interventions Experimental Device
Lead sponsor Abbott Medical Devices Industry
Eligibility 18 Years and older
Enrollment 335 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 40
States / cities Scottsdale, Arizona • Little Rock, Arkansas • Los Angeles, California + 33 more
Conditions Osteoarthritis, Knee, Chronic Pain
Interventions LY4065967, Placebo Drug
Lead sponsor Eli Lilly and Company Industry
Eligibility 40 Years and older
Enrollment 150 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2027
U.S. locations 36
States / cities Birmingham, Alabama • Phoenix, Arizona • Palm Springs, California + 31 more
Conditions HIV/AIDS, Nicotine Dependence
Interventions Varenicline, Nicotine patch, Standard treatment, Standard treatment + Managed Problem Solving (MAPS) adherence intervention Drug · Behavioral
Lead sponsor Abramson Cancer Center at Penn Medicine Other
Eligibility 18 Years and older
Enrollment 340 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2026
U.S. locations 2
States / cities Chicago, Illinois • Philadelphia, Pennsylvania
Conditions Advanced Solid Tumor, Adult, ERBB2 Altered Breast Cancer, ERBB2 Gene Amplification, HER2 Overexpression, Non-Small Cell Lung Cancer, HER2
Interventions CGT4255 Drug
Lead sponsor Cogent Biosciences, Inc. Industry
Eligibility 18 Years and older
Enrollment 100 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 15
States / cities Scottsdale, Arizona • New Haven, Connecticut • Jacksonville, Florida + 11 more
Conditions Parkinsons Disease
Interventions Prasinezumab, Placebo Drug
Lead sponsor Hoffmann-La Roche Industry
Eligibility 50 Years to 85 Years
Enrollment 586 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2031
U.S. locations 31
States / cities Birmingham, Alabama • Phoenix, Arizona • Fullerton, California + 27 more About this Northwestern Medicine institution page
What this page lists ClinicalTrials.gov records that list Northwestern Medicine in Chicago, IL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , trials led by Northwestern University at any site , browse by condition , or browse by U.S. city .